Advertisement

Acta Parasitologica

, Volume 63, Issue 1, pp 33–39 | Cite as

A serological study of antibodies to Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in the sera of healthy individuals collected two decades apart

  • Bohumír Kříž
  • Marek Malý
  • Pavla Balátová
  • Petr Kodym
  • Zuzana Kurzová
  • Milan Daniel
  • Kateřina KybicováEmail author
Article

Abstract

Sera collected from healthy individuals from the general population in the Czech Republic during repeated cross-sectional surveys were analyzed. Samples collected in the same six districts in two time periods, 1978–1989 and 2001, were compared. The study subjects were divided into six age categories between 10 and 59 years. Overall, 434 samples from 1978–1989 and 270 samples from 2001 were screened for Anaplasma phagocytophilum (AP) and Borrelia burgdorferi sensu lato (BB). The antiAP positivity rates were 13.1% and 11.5% in the first and second period, respectively, and did not differ significantly between the periods (P = 0.559). The anti-BB antibodies were detected in 33.9% and 14.8% of study subjects, respectively. The positivity rates were significantly lower in the second period (P>0.001). No considerable changes were observed in the sex distribution of positive findings between the two periods. The highest positivity rates of anti-AP antibodies were found in the 10–14 year age group: 16.0% in 1978–1989 and 16.7% in 2001. The age distribution of the anti-AP antibody positivity rates did not change substantially (P = 0.872). In 1978–1989, the lowest anti-BB antibody positivity rate (26.7%) was found in the 10–14 year age group, with a gradual increase with age to 41.1% in 50–59 year-olds. In 2001, the positivity rate in the 10–14 year age group was 26.2% and was not significantly different from that in the first period (P = 0.955). However, the positivity rates in the older age groups 15–59 years decreased significantly (P<0.001) and varied between 8.3% and 15.1%.

Keywords

Borrelia burgdorferi Anaplasma antibodies distribution epidemiology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aguero-Rosenfeld M.E., Kalantarpour F., Baluch M., Horowitz H.W., McKenna D.F., Raffalli J.T., et al. 2000. Serology of culture-confirmed cases of human granulocytic ehrlichiosis. Journal of Clinical Microbiology, 38, 635–638PubMedPubMedCentralGoogle Scholar
  2. Bakken J.S., Dumler J.S. 2006. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Annals of the New York Academy of Sciences. 1078, 236–247. DOI: 10.1196/annals.1374.042CrossRefGoogle Scholar
  3. Balátová P., Kurzová Z., Hulínská D. 2011. Sérologie lymeské borreliózy a humánní granulocytární ehrlichiózy v letech 2005–2010. Epidemiologie, Mikrobiologie, Imunologie, 60, 74–76Google Scholar
  4. Bartůnĕk P., Mrázek V., Varejka P., Sklenár T., Bína R., Listvanová S., Janovská D. 2000. Výpovědní hodnota prevalence antiboreliových protilátek u zdravé a rizikové populace. Epidemiologie, Mikrobiologie, Imunologie, 49, 4–10PubMedGoogle Scholar
  5. Basta J., Plch J., Hulínská D., Daniel M. 1999. Incidence of Borrelia garinii and Borrelia afzelii in Ixodes ricinus ticks in an urban environment. European Journal of Clinical Microbiology & Infectious Diseases, 18, 515–517. DOI: 10.1007/s100960050335CrossRefGoogle Scholar
  6. Bazovská S., Guryčová D., Výrosteková V., Jareková J., Bakoss, P., Macháčová, E., Špaleková, M. 2010. Protilátky proti pôvodcom niektorých prírodne ohniskových nákaz v sérach darcov krvi zo západného Slovenska. Epidemiologie, Mikrobiologie, Imunologie, 59, 168–171Google Scholar
  7. Biesiada G., Czepiel J., Leśniak M.R., Garlicki A., Mach T. 2012. Lyme disease: review. Archives of Medical Science, 8, 978–982. DOI: 10.5114/aoms.2012.30948CrossRefGoogle Scholar
  8. Chochlakis D., Papaeustathiou A., Minadakis G., Psaroulaki A., Tselentis Y. 2008. A serosurvey of Anaplasma phagocytophilum in blood donors in Crete, Greece. European Journal of Clinical Microbiology & Infectious Diseases, 27, 473–475. DOI: 10.1007/s10096-007-0457-3CrossRefGoogle Scholar
  9. Danielová V., Daniel M., Rudenko N., Golovchenko M. 2004. Prevalence of Borrelia burgdorferi sensu lato genospecies in hostseeking Ixodes ricinus ticks in selected South Bohemian locations (Czech Republic). Central European Journal of Public Health, 12, 151–156PubMedGoogle Scholar
  10. Denis D.T., Hayes E.B. 2002. Epidemiology of Lyme borreliosis. In: (Eds. J. Gray, O. Kahl, R.S. Lane and G. Stanek) Lyme borreliosis: Biology, epidemiology and control. CABI Publishing, Oxford, 251–280. DOI: 10.1079/9780851996325.0000CrossRefGoogle Scholar
  11. Dessau R.B., Bangsborg J.M., Ejlertsen T., Skarphedinsson S., Schønheyder H.C. 2010. Utilization of serology for the diagnosis of suspected Lyme borreliosis in Denmark: survey of patients seen in general practice. BMC Infectious Diseases, 10, 317. DOI: 10.1186/1471-2334-10-317CrossRefGoogle Scholar
  12. Dvořáková-Heroldová M., Dvořáčková M. 2014. Séroprevalence Anaplasma phagocytophilum u pacientů se suspektní lymeskou borreliózou. Epidemiologie, Mikrobiologie, Imunologie, 63, 297–302PubMedGoogle Scholar
  13. Esposito S., Bosis S., Sabatini C., Tagliaferri L., Principi N. 2013. Borrelia burgdorferi infection and Lyme disease in children. International Journal of Infectious Diseases, 17, 153–158. DOI: 10.1016/j.ijid.2012.09.014CrossRefGoogle Scholar
  14. Feder H.M., Jr, Gerber M.A., Luger S.W., Ryan R.W. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis. 1992 Nov; 15, 788–93Google Scholar
  15. Glatz M., Golestani M., Kerl H., Müllegger R.R. 2006. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Archives of Dermatology. 142, 862–868. DOI: 10.1001/archderm.142.7.862CrossRefGoogle Scholar
  16. Grubhoffer L., Golovchenko M., Vancová M., Zacharovová-Slavícková K., Rudenko N., Oliver J.H. Jr. 2005. Lyme borreliosis: insights into tick-/host-borrelia relations. Folia Parasitologica. 52, 279–294CrossRefGoogle Scholar
  17. Grzeszczuk A., Stańczak J., Kubica-Biernat B., Racewicz M., Kruminis-Łozowska W., Prokopowicz D. 2004. Human anaplasmosis in north-eastern Poland: seroprevalence in humans and prevalence in Ixodes ricinus ticks. Annals of Agricultural and Environmental Medicine, 11, 99–103PubMedGoogle Scholar
  18. Gustafson R., Svenungsson B., Gardulf A., Stiernstedt G., Forsgren M. 1990. Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population. Scandinavian Journal of Infectious Diseases, 22, 297–306CrossRefGoogle Scholar
  19. Gustafson R., Forsgren M., Gardulf A., Granström M., Svenungsson B. 1993. Antibody prevalence and clinical manifestations of Lyme borreliosis and tick-borne encephalitis in Swedish orienteers. Scandinavian Journal of Infectious Diseases, 25, 605–611CrossRefGoogle Scholar
  20. Hájek T., Libiger J., Janovská D., Hájek P., Alda M., Höschl C. 2006. Clinical and demographic characteristics of psychiatric patients seropositive for Borrelia burgdorferi. European Psychiatry, 21, 118–122. DOI: 10.1016/j.eurpsy.2004.09.021CrossRefGoogle Scholar
  21. Hammers-Berggren S., Lebech A.M., Karlsson M., Svenungsson B., Hansen K., Stiernstedt G. 1994. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. Journal of Clinical Microbiology, 32, 1519–1525PubMedPubMedCentralGoogle Scholar
  22. Hubálek Z. 2009. Epidemiology of lyme borreliosis. Current Problems in Dermatology, 37, 31–50. DOI: 10.1159/000213069CrossRefGoogle Scholar
  23. Hulínská D., Votýpka J., Vaňousová D., Hercogová J., Hulínský V., Drevová H., Kurzová Z., Uherková L. 2009. Identification of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in patients with erythema migrans. Folia Microbiologica. 54, 246–256. DOI: 10.1007/s12223-009-0039-0CrossRefGoogle Scholar
  24. Jirous J., Pokorný J., Zástĕra M., Doutlík S., Bojar M. 1988. First experience with ELISA serosurvey for tick-borne borreliosis (Lyme disease) in Czechoslovakia. Journal of Hygiene, Epidemiology, Microbiology, and Immunology, 32, 169–172PubMedGoogle Scholar
  25. Krbkova L., Stanek G. 1996. Therapy of Lyme borreliosis in children. Infection, 24, 170–173CrossRefGoogle Scholar
  26. Kriz B., Hubalek Z., Maly M., Daniel M., Strakova P., Betasova L. 2015. Results of the screening of tick-borne encephalitis virus antibodies in human sera from eight districts collected two decades apart. Vector-Borne and Zoonotic Diseases, 15, 489–493. DOI: 10.1089/vbz.2014.1747CrossRefGoogle Scholar
  27. Lásiková S., Moravcová L., Pícha D., Holečková D., Žďárský E. 2004. Detekce antiehrlichiových protilátek a přímý průkaz ehrlichiové nukleové kyseliny polymerázovou řetězovou reakcí (PCR) u pacientů v České republice. Klinická mikrobiologie a infekční lékařství,10, 25–29PubMedGoogle Scholar
  28. Lotrič-Furlan S., Petrovec M., Avsic-Zupanc T., Logar M., Strle F. 2002. Epidemiological, clinical and laboratory distinction between human granulocytic ehrlichiosis and the initial phase of tick-borne encephalitis. Wiener klinische Wochenschrift, 114, 636–640PubMedGoogle Scholar
  29. Ongut G., Ogunc D., Mutlu G., Colak D., Gultekin M., Gunseren F., Donmez L., Tuncer D. 2006. Seroprevalence of antibodies to Anaplasma phagocytophilum in Antalya, Turkey. Infection, 34, 107–109. DOI: 10.1007/s15010-006-5040-9CrossRefGoogle Scholar
  30. Pazdiora P., Topolčan O., Benešová J., Böhm K., Brejcha O., Kubátová A., et al. 1994. Surveillance lymské boreliózy v Západočeském kraji, výskyt protilátek u pracovníků lesních závodů. Plzeňský lékařský sborník Supplementum, 69, 61Google Scholar
  31. Rojko T., Ruzić-Sabljić E., Strle F., Lotric-Furlan S. 2005. Prevalence and incidence of Lyme borreliosis among Slovene forestry workers during the period of tick activity. Wiener klinische Wochenschrift, 117, 219–225CrossRefGoogle Scholar
  32. Skogman B.H., Ekerfelt C., Ludvigsson J., Forsberg P. 2010. Seroprevalence of Borrelia IgG antibodies among young Swedish children in relation to reported tick bites, symptoms and previous treatment for Lyme borreliosis: a population-based survey. Archives of Disease in Childhood, 95, 1013–1016. DOI: 10.1136/adc.2010.183624CrossRefGoogle Scholar
  33. Stanek G., Fingerle V., Hunfeld K.-P., Jaulhac B., Kaiser R., Krause A., et al. 2011. Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe. Clinical Micribiology and Infection, 17, 69–79. DOI: 10.1111/j.1469-0691.2010.03175.xCrossRefGoogle Scholar
  34. Stanek G., Wormser G.P., Gray J., Strle F. 2012. Lyme borreliosis. Lancet, 379, 461–473. DOI: 10.1016/S0140-6736(11)60103-7CrossRefGoogle Scholar
  35. Strle F. 2004. Human granulocytic ehrlichiosis in Europe. International Journal of Medical Microbiology, 293, 27–35PubMedGoogle Scholar
  36. Stuen S., Granquist E.G., Silaghi C. 2013. Anaplasma phagocytophilum–a widespread multi-host pathogen with highly adaptive strategies. Frontiers in Cellular and Infection Microbiology, 3, 31. DOI: 10.3389/fcimb.2013.00031CrossRefGoogle Scholar
  37. Thorin C., Rigaud E., Capek I., André-Fontaine G., Oster B., Gastinger G., Abadia G. 2008. Séroprévalence de la borréliose de Lyme et de l’encéphalite à tiques chez des professionnels exposés dans le Grand Est de la France. Médecine et Maladies Infectieuses, 38, 533–542. DOI: 10.1016/j.medmal.2008.06.008CrossRefGoogle Scholar
  38. Zákutná L., Dorko E., Rimárová K., Kizeková M. 2015. Pilot cross-sectional study of three zoonoses (Lyme disease, Tuaremia, Leptospirosis) among healthy blood donors in eastern Slovakia. Central European Journal of Public Health, 23, 100–106. DOI: 10.21101/cejph.a4052CrossRefGoogle Scholar
  39. Zeman P. 2002. Srovnání některých extrakčních postupů pro průkazehrlichiové DNA metodou PCR v plné krvi. Epidemiologie, Mikrobiologie, Imunologie, 51, 143–147PubMedGoogle Scholar
  40. Zeman P., Pazdiora P., Rébl K., Činátl J. 2002. Výskyt protilátek proti granulocytárním ehrlichiím u západočeské a středočeské populace. Epidemiologie, Mikrobiologie, Imunologie, 51, 13–18PubMedGoogle Scholar

Copyright information

© Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2018

Authors and Affiliations

  • Bohumír Kříž
    • 1
    • 2
  • Marek Malý
    • 1
  • Pavla Balátová
    • 1
  • Petr Kodym
    • 1
  • Zuzana Kurzová
    • 1
  • Milan Daniel
    • 1
  • Kateřina Kybicová
    • 1
    Email author
  1. 1.National Institute of Public HealthPraha 10Czech Republic
  2. 2.3rd Medical FacultyCharles UniversityPraha 10Czech Republic

Personalised recommendations